Table of Content


Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope and definitions
1.3 Base estimates and working
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Pharmacovigilance industry 360 degree synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Clinical trial phase trends
2.1.4 Service provider trends
2.1.5 End-user trends
2.1.6 Regional trends
Chapter 3 Pharmacovigilance Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 – 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing need of new drugs
3.3.1.2 Rising investment on R&D by pharmaceutical companies
3.3.1.3 Rise in incidences of adverse drug reactions (ADR) and drug toxicity
3.3.1.4 Increasing focus on personalized medicine
3.3.1.5 Increasing trend of outsourcing pharmacovigilance services
3.3.2 Industry pitfalls & challenges
3.3.2.1 High risk associated with data security
3.3.2.2 Lack of skilled healthcare professionals
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By clinical trial phase
3.4.3 By service provider
3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Technology landscape
3.7.1 Artificial intelligence (AI) in pharmacovigilance
3.7.2 Natural language processing (NLP) in pharmacovigilance
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company positioning matrix
4.4 Competitive analysis of major market players
4.5 Strategic outlook matrix
4.6 Company market share analysis, 2022
4.7 Strategy dashboard, 2022
Chapter 5 Pharmacovigilance Market, By Type
5.1 Key type trends
5.2 Software
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Service
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 By Process
5.3.2.1 Core services
5.3.2.1.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2.2 Consulting services
5.3.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 By Activity
5.3.3.1 Spontaneous Reporting
5.3.3.1.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3.2 Intensified Adverse Drug Reaction (ADR) Reporting
5.3.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3.3 Cohort Event Monitoring
5.3.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3.4 EHR Mining
5.3.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3.5 Others
5.3.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Pharmacovigilance Market, By Clinical Trial Phase
6.1 Key clinical trial phase trends
6.2 Pre-clinical
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Phase 1
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Phase 2
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Phase 3
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Phase 4
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Pharmacovigilance Market, By Service Provider
7.1 Key service provider trends
7.2 In-house
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Contract outsourcing
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Pharmacovigilance Market, By End-use
8.1 Key end-use trends
8.2 Pharmaceutical & biotechnological companies
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Medical device companies
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Hospitals
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Others
8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Pharmacovigilance Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Qatar
9.6.5 Israel
9.6.6 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Accenture
10.2 Cognizant
10.3 Labcorp Drug Development
10.4 IBM Corporation
10.5 ArisGlobal
10.6 ICON plc
10.7 United BioSource LLC
10.8 Pharmaceutical Development Group, Inc.
10.9 Wipro Limited
10.10 Allucent

Data Tables
TABLE 1. Market revenue, by type, 2022
TABLE 2. Market revenue, by clinical trial phase, 2022
TABLE 3. Market revenue, by service provider, 2022
TABLE 4. Market revenue, by end-use, 2022
TABLE 5. Market share, by region, 2022
TABLE 6. Global pharmacovigilance market, 2018-2022 (USD Million)
TABLE 7. Global pharmacovigilance market, 2023 – 2032 (USD Million)
TABLE 8. Global pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 9. Global pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 10. Global pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 11. Global pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 12. Global pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 13. Global pharmacovigilance market, by service provider, 2023 – 2032 (USD Million)
TABLE 14. Global pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 15. Global pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 16. Global pharmacovigilance market, region, 2018-2022 (USD Million)
TABLE 17. Global pharmacovigilance market, region, 2023 – 2032 (USD Million)
TABLE 18. Industry impact forces
TABLE 19. Software market estimates and forecast, 2018-2022 (USD Million)
TABLE 20. Software market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 21. Service market estimates and forecast, 2018-2022 (USD Million)
TABLE 22. Service market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 23. Core services market estimates and forecast, 2018-2022 (USD Million)
TABLE 24. Core services market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 25. Consulting services market estimates and forecast, 2018-2022 (USD Million)
TABLE 26. Consulting services market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 27. Spontaneous reporting market estimates and forecast, 2018-2022 (USD Million)
TABLE 28. Spontaneous reporting market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 29. Intensified Adverse Drug Reaction (ADR) reporting market estimates and forecast, 2018-2022 (USD Million)
TABLE 30. Intensified Adverse Drug Reaction (ADR) reporting market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 31. Cohort event monitoring market estimates and forecast, 2018-2022 (USD Million)
TABLE 32. Cohort event monitoring market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 33. EHR mining market estimates and forecast, 2018-2022 (USD Million)
TABLE 34. EHR mining market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 35. Other activities market estimates and forecast, 2018-2022 (USD Million)
TABLE 36. Other activities market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 37. Pre-clinical animals market estimates and forecast, 2018-2022 (USD Million)
TABLE 38. Pre-clinical animals market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 39. Phase 1 market estimates and forecast, 2018-2022 (USD Million)
TABLE 40. Phase 1 market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 41. Phase 2 market estimates and forecast, 2018-2022 (USD Million)
TABLE 42. Phase 2 market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 43. Phase 3 market estimates and forecast, 2018-2022 (USD Million)
TABLE 44. Phase 3 market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 45. Phase 4 and goats market estimates and forecast, 2018-2022 (USD Million)
TABLE 46. Phase 4 and goats market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 47. In-house market estimates and forecast, 2018-2022 (USD Million)
TABLE 48. In-house market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 49. Contract outsourcing market estimates and forecast, 2018-2022 (USD Million)
TABLE 50. Contract outsourcing market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 51. Pharmaceutical & biotechnological companies market estimates and forecast, 2018-2022 (USD Million)
TABLE 52. Pharmaceutical & biotechnological companies market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 53. Medical device companies market estimates and forecast, 2018-2022 (USD Million)
TABLE 54. Medical device companies market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 55. Hospitals market estimates and forecast, 2018-2022 (USD Million)
TABLE 56. Hospitals market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 57. Others market estimates and forecast, 2018-2022 (USD Million)
TABLE 58. Others market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 59. North America pharmacovigilance market, by country, 2018-2022 (USD Million)
TABLE 60. North America pharmacovigilance market, by country, 2023 – 2032 (USD Million)
TABLE 61. North America pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 62. North America pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 63. North America pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 64. North America pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 65. North America pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 66. North America pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 67. North America pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 68. North America pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 69. North America pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 70. North America pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 71. North America pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 72. North America pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 73. U.S. pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 74. U.S. pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 75. U.S. pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 76. U.S. pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 77. U.S. pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 78. U.S. pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 79. U.S. pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 80. U.S. pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 81. U.S. pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 82. U.S. pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 83. U.S. pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 84. U.S. pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 85. Canada pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 86. Canada pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 87. Canada pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 88. Canada pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 89. Canada pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 90. Canada pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 91. Canada pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 92. Canada pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 93. Canada pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 94. Canada pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 95. Canada pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 96. Canada pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 97. Europe pharmacovigilance market, by country, 2018-2022 (USD Million)
TABLE 98. Europe pharmacovigilance market, by country, 2023 – 2032 (USD Million)
TABLE 99. Europe pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 100. Europe pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 101. Europe pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 102. Europe pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 103. Europe pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 104. Europe pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 105. Europe pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 106. Europe pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 107. Europe pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 108. Europe pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 109. Europe pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 110. Europe pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 111. Germany pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 112. Germany pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 113. Germany pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 114. Germany pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 115. Germany pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 116. Germany pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 117. Germany pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 118. Germany pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 119. Germany pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 120. Germany pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 121. Germany pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 122. Germany pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 123. UK pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 124. UK pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 125. UK pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 126. UK pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 127. UK pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 128. UK pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 129. UK pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 130. UK pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 131. UK pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 132. UK pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 133. UK pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 134. UK pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 135. France pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 136. France pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 137. France pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 138. France pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 139. France pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 140. France pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 141. France pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 142. France pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 143. France pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 144. France pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 145. France pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 146. France pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 147. Italy pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 148. Italy pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 149. Italy pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 150. Italy pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 151. Italy pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 152. Italy pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 153. Italy pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 154. Italy pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 155. Italy pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 156. Italy pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 157. Italy pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 158. Italy pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 159. Spain pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 160. Spain pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 161. Spain pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 162. Spain pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 163. Spain pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 164. Spain pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 165. Spain pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 166. Spain pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 167. Spain pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 168. Spain pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 169. Spain pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 170. Spain pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 171. Rest of Europe pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 172. Rest of Europe pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 173. Rest of Europe pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 174. Rest of Europe pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 175. Rest of Europe pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 176. Rest of Europe pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 177. Rest of Europe pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 178. Rest of Europe pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 179. Rest of Europe pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 180. Rest of Europe pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 181. Rest of Europe pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 182. Rest of Europe pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 183. Asia Pacific pharmacovigilance market, by country, 2018-2022 (USD Million)
TABLE 184. Asia Pacific pharmacovigilance market, by country, 2023 – 2032 (USD Million)
TABLE 185. Asia Pacific pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 186. Asia Pacific pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 187. Asia Pacific pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 188. Asia Pacific pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 189. Asia Pacific pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 190. Asia Pacific pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 191. Asia Pacific pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 192. Asia Pacific pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 193. Asia Pacific pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 194. Asia Pacific pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 195. Asia Pacific pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 196. Asia Pacific pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 197. China pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 198. China pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 199. China pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 200. China pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 201. China pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 202. China pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 203. China pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 204. China pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 205. China pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 206. China pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 207. China pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 208. China pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 209. India pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 210. India pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 211. India pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 212. India pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 213. India pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 214. India pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 215. India pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 216. India pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 217. India pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 218. India pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 219. India pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 220. India pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 221. Japan pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 222. Japan pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 223. Japan pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 224. Japan pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 225. Japan pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 226. Japan pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 227. Japan pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 228. Japan pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 229. Japan pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 230. Japan pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 231. Japan pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 232. Japan pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 233. Australia pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 234. Australia pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 235. Australia pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 236. Australia pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 237. Australia pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 238. Australia pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 239. Australia pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 240. Australia pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 241. Australia pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 242. Australia pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 243. Australia pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 244. Australia pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 245. Rest of Asia Pacific pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 246. Rest of Asia Pacific pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 247. Rest of Asia Pacific pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 248. Rest of Asia Pacific pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 249. Rest of Asia Pacific pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 250. Rest of Asia Pacific pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 251. Rest of Asia Pacific pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 252. Rest of Asia Pacific pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 253. Rest of Asia Pacific pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 254. Rest of Asia Pacific pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 255

List of Tables

TABLE 311. Rest of Latin America pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 312. Rest of Latin America pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 313. Rest of Latin America pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 314. Rest of Latin America pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 315. Rest of Latin America pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 316. Rest of Latin America pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 317. Rest of Latin America pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 318. Rest of Latin America pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 319. MEA pharmacovigilance market, by country, 2018-2022 (USD Million)
TABLE 320. MEA pharmacovigilance market, by country, 2023 – 2032 (USD Million)
TABLE 321. MEA pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 322. MEA pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 323. MEA pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 324. MEA pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 325. MEA pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 326. MEA pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 327. MEA pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 328. MEA pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 329. MEA pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 330. MEA pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 331. MEA pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 332. MEA pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 333. South Africa pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 334. South Africa pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 335. South Africa pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 336. South Africa pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 337. South Africa pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 338. South Africa pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 339. South Africa pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 340. South Africa pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 341. South Africa pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 342. South Africa pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 343. South Africa pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 344. South Africa pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 345. Saudi Arabia pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 346. Saudi Arabia pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 347. Saudi Arabia pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 348. Saudi Arabia pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 349. Saudi Arabia pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 350. Saudi Arabia pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 351. Saudi Arabia pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 352. Saudi Arabia pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 353. Saudi Arabia pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 354. Saudi Arabia pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 355. Saudi Arabia pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 356. Saudi Arabia pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 357. UAE pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 358. UAE pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 359. UAE pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 360. UAE pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 361. UAE pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 362. UAE pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 363. UAE pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 364. UAE pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 365. UAE pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 366. UAE pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 367. UAE pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 368. UAE pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 369. Qatar pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 370. Qatar pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 371. Qatar pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 372. Qatar pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 373. Qatar pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 374. Qatar pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 375. Qatar pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 376. Qatar pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 377. Qatar pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 378. Qatar pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 379. Qatar pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 380. Qatar pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 381. Israel pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 382. Israel pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 383. Israel pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 384. Israel pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 385. Israel pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 386. Israel pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 387. Israel pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 388. Israel pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 389. Israel pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 390. Israel pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 391. Israel pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 392. Israel pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)
TABLE 393. Rest of Middle East & Africa pharmacovigilance market, by type, 2018-2022 (USD Million)
TABLE 394. Rest of Middle East & Africa pharmacovigilance market, by type, 2023 – 2032 (USD Million)
TABLE 395. Rest of Middle East & Africa pharmacovigilance market, by process, 2018-2022 (USD Million)
TABLE 396. Rest of Middle East & Africa pharmacovigilance market, by process, 2023–2032 (USD Million)
TABLE 397. Rest of Middle East & Africa pharmacovigilance market, by activity, 2018-2022 (USD Million)
TABLE 398. Rest of Middle East & Africa pharmacovigilance market, by activity, 2023–2032 (USD Million)
TABLE 399. Rest of Middle East & Africa pharmacovigilance market, by clinical trial phase, 2018-2022 (USD Million)
TABLE 400. Rest of Middle East & Africa pharmacovigilance market, by clinical trial phase, 2023 – 2032 (USD Million)
TABLE 401. Rest of Middle East & Africa pharmacovigilance market, by service provider, 2018-2022 (USD Million)
TABLE 402. Rest of Middle East & Africa pharmacovigilance market, by service provider, 2023–2032 (USD Million)
TABLE 403. Rest of Middle East & Africa pharmacovigilance market, by end-use, 2018-2022 (USD Million)
TABLE 404. Rest of Middle East & Africa pharmacovigilance market, by end-use, 2023 – 2032 (USD Million)

Charts & Figures
FIG. 1 GMI report coverage: Critical research elements
FIG. 2 Industry segmentation
FIG. 3 Top-down approach
FIG. 4 Market estimation and forecast methodology
FIG. 5 Market forecasting methodology
FIG. 6 Breakdown of primary participants
FIG. 7 Global pharmacovigilance industry 360 degree synopsis, 2018 - 2032 (USD Mn)
FIG. 8 Growth potential analysis, by type
FIG. 9 Growth potential analysis, by clinical trial phase
FIG. 10 Growth potential analysis, by service provider
FIG. 11 Growth potential analysis, by end-use
FIG. 12 Company matrix analysis
FIG. 13 Competitive analysis of major market players
FIG. 14 Competitive positioning matrix
FIG. 15 Strategic outlook matrix
FIG. 16 Company market share analysis, 2022
FIG. 17 Strategic dashboard